Skip to Content

TAK ALG-6.25 (Alogliptin benzoate 6.25 mg)

Pill imprint TAK ALG-6.25 has been identified as Alogliptin benzoate 6.25 mg.

Alogliptin is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Alogliptin 6.25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Alogliptin benzoate
TAK ALG-6.25
6.25 mg
Elliptical / Oval
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Perrigo New York Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.